Welcome to our dedicated page for CME Group news (Ticker: CME), a resource for investors and traders seeking the latest updates and insights on CME Group stock.
CME Group Inc. operates a derivatives marketplace that supports trading and clearing in futures, options, cash and OTC markets. Its exchanges list benchmark products tied to interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals, with trading conducted through CME Globex, fixed income markets through BrokerTec, foreign exchange through EBS and central counterparty services through CME Clearing.
Company news commonly covers quarterly results, clearing and transaction fee revenue, market data revenue, dividends, new futures and options contracts, benchmark administration and regulatory approvals affecting clearing or margin services. Recurring updates also include cryptocurrency and equity index product expansion, U.S. repo and Term SOFR reference-rate activity, and the Purdue University/CME Group Ag Economy Barometer.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
CME Group reported strong financial results for Q1 2023, showcasing the highest adjusted net income and earnings per share ever. Revenue reached $1.4 billion with an operating income of $914 million and a net income of $884 million, translating to diluted earnings per share of $2.43. The quarterly adjusted net income stood at $882 million, with adjusted earnings per share at $2.42.
Daily volumes exceeded 25 million contracts on 28 occasions, including a record of 66.3 million contracts on March 13. The company's clearing and transaction fees generated $1.2 billion. Cash reserves totaled $1.7 billion, while the total debt was $3.4 billion. CME Group continues to return value to shareholders, having paid approximately $2.0 billion in dividends during the quarter.